TCM Ltd Stock Price Today (NSE: TCMLMTD)

TCM Ltd

49.40+0.89 (+1.83%)
Market Closed

Fundamental Score

...

TCM Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

TCM Ltd share price today is 49.40, up +1.83% on NSE/BSE as of 19 June 2026. TCM Ltd (TCMLMTD) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 54.71 (Cr). The 52-week high for TCMLMTD share price is 81.00 and the 52-week low is 36.53. At a P/E ratio of 364.75x, TCMLMTD is currently trading above its industry average P/E of 20.98x. The company has a Return on Equity (ROE) of 6.04% and a debt-to-equity ratio of 0.75.

TCM Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
53.02
Low
39.11
Volume
10.4K
Change
+2.53%

TCM Ltd share price chart: 2.53% return over the past month. 52-week high ₹81.00, 52-week low ₹36.53.

TCM Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
49.4050.0048.5549.404.67K (Cr)
49.0049.0048.0048.51909.00 (Cr)
49.0949.0947.7048.062.00K (Cr)
51.6051.6149.0049.095.43K (Cr)
48.2851.3546.2150.665.12K (Cr)
50.8050.8048.0048.285.26K (Cr)
49.9950.8748.0048.564.57K (Cr)
50.0150.8946.5050.063.52K (Cr)
51.5053.0248.1149.6246.02K (Cr)
41.5849.7240.2249.621.11L (Cr)

TCM Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
49.0050.0048.0049.40+0.82%
44.0653.0239.1148.06+9.08%
40.0051.9440.0044.27+10.68%
46.5347.8036.5339.22-15.71%
52.7054.3346.0846.53-11.71%
63.9263.9848.5249.27-22.92%
73.0074.9959.8564.14-12.14%
59.6881.0054.5270.72+18.50%
44.2058.7541.3557.53+30.16%
40.0052.9039.8843.20+8.00%
41.0043.9037.1039.69-3.20%
41.2044.7938.2540.28-2.23%

AI Research Briefing

Powered by Gemini · 2026-04-09

Micro-cap commodity chemicals player with negative profitability and expensive valuation; avoid until execution improves.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEConsolidation after recent 1M/3M gains.Expensive (P/E: 364.75x) compared to industry (20.98x).

WHAT'S HAPPENING NOW (last 2-4 weeks)

TCM Ltd. will close its trading window from April 1, 2026, until 48 hours after Q4 FY26 results are announced, to prevent insider trading. MarketsMojo maintains a 'Sell' rating as of March 6, 2026, citing below-average quality, risky valuation, and mixed technical signals.

CORE STORY (THE REAL GAME)

TCM is a micro-cap commodity chemicals player attempting a pivot into solar and other ventures, but struggling with profitability and consistency. It's a diversification play with execution risk.

Why Now
  • Solar contract execution pending
  • Acquisition due diligence ongoing
  • Recent technical bounce despite weak fundamentals
Potential Catalysts
  • Successful execution of solar contract
  • Closure of Better Feeds acquisition
  • Commodity chemical price upswing
Key Risks
  • Micro-cap liquidity risk
  • Negative profitability
  • High valuation
Institutional Activity

No significant FII/DII activity. Promoter holding stable at 49.51%.

Macro Context

India's chemical industry is projected to grow, but TCM's specific segment faces challenges.

Order Book / Expansion

₹79.2 Cr solar contract from CIAL Infrastructures.

Cash Flow Quality

Negative free cash flow (₹-23.34 Cr over 5 years).

3–6 Month Outlook

3-6 months: Monitor solar contract execution and acquisition progress. Thesis hinges on successful turnaround; otherwise, expect further downside.

Primary Thesis Risk

Inability to execute solar contracts and integrate acquisitions will lead to value erosion.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

6.04%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.32%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-17.35%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

TCM Ltd Valuation Check

Poor

Price to Earnings (P/E)

364.75x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

20.98x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

49.51%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Average

DII Holding

7.44%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-36.84%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-14.20%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

95.11%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

43.02%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

42.94%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.75x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

0.91x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-23.34 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

TCM Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TCMLMTD across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Consistent Growth Track Record (95.11% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (43.02% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (42.94% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

10 factors identified

Below-Average Return on Equity (6.04%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.32%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-17.35%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 364.75x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-36.84%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-14.20%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Weak Interest Coverage (0.91x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-23.34 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 7.44%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

TCM Ltd vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare TCM Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
33.9/100
49
₹54.71
364.8
Average
6.04%
Poor
6.32%
Poor
0.8
Good
42.94%
Excellent
95.11%
Excellent
0.00%
SRF Ltd...
SRF503806
49.8/100
2737
₹86606.52
53.5
Average
10.37%
Average
12.27%
Average
0.3
Excellent
4.40%
Average
15.30%
Excellent
0.25%
14.9/100
775
₹20261.08
62.2
Average
1.20%
Poor
3.96%
Poor
0.3
Excellent
-47.92%
Poor
7.53%
Good
1.38%
57/100
1448
₹17120.52
17.4
Average
15.56%
Good
15.67%
Good
0.7
Good
94.55%
Excellent
17.00%
Excellent
0.74%
52.8/100
516
₹7381.56
11.6
Average
7.08%
Poor
9.57%
Poor
0.0
Excellent
3.30%
Average
8.86%
Good
3.58%
Ghcl Ltd...
GHCL500171
40.4/100
463
₹5520.31
9.7
Average
18.57%
Good
24.19%
Excellent
0.0
Excellent
8.63%
Good
-0.75%
Poor
2.09%
19.7/100
18
₹5397.73
9306.4
Average
2.12%
Poor
2.57%
Poor
0.0
Excellent
173.71%
Excellent
0.00%
24.4/100
222
₹4503.74
-5.93%
Poor
1.83%
Poor
1.0
Good
28.15%
Excellent
0.00%
68.7/100
1972
₹4106.65
43.7
Average
32.05%
Excellent
41.76%
Excellent
0.1
Excellent
38.64%
Excellent
27.58%
Excellent
0.22%
28/100
687
₹3866.17
25774.5
Average
-1.13%
Poor
-0.34%
Poor
0.1
Excellent
8.37%
Good
3.01%
59.7/100
72
₹3614.14
23.9
Average
17.58%
Good
23.34%
Excellent
0.0
Excellent
17.17%
Excellent
12.90%
Good
0.63%

TCM Ltd Quarterly Performance

Latest quarterly metrics for TCMLMTD — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-14.20%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-36.84%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

95.11%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

42.94%

Compounded annual net profit growth over 5 years

TCM Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TCMLMTD — calculated from daily price history

63RSI 14
Neutral — RSI 63

Momentum is balanced — neither overbought nor oversold.

SMA 50
45
▲ Price above SMA 50 — Short-term bullish
SMA 200
51
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
8K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

TCM Ltd Financial Statements

Annual income statement, balance sheet and cash flow for TCM Ltd (TCMLMTD) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for TCM Ltd

About TCMLMTD (TCM Ltd)

TCM Ltd is a multifaceted entity deeply entrenched in the commodity chemicals sector, operating on a global scale. The company distinguishes itself through a comprehensive business... model that encompasses the entire value chain, from the meticulous manufacture of raw materials to the strategic trading of specialized chemical compounds. TCM Ltd's core competency lies in the production of a diverse portfolio of organic and inorganic chemicals, catering to a wide array of industrial applications. They are also a substantial producer of specialty chemicals, including vital components in the agriculture sector such as fungicides and herbicides, along with a range of barium and strontium salts that are essential to various manufacturing processes. TCM Ltd is committed to providing both high-quality products and logistical solutions for industrial clients. Beyond its chemical manufacturing, TCM Ltd demonstrates a commitment to product diversity, extending its reach into other areas. A significant aspect of its operations involves the trade of auto care and health care related products, showcasing its agility in adapting to market demands and consumer needs. The company further invests in the development, distribution, and maintenance of diagnostic equipment and related reagents, providing a valuable service to laboratories and research institutions. This blend of chemical production with the supply of specialized products positions TCM Ltd as a unique player within the commodity chemicals market. They are able to offer comprehensive solutions to clients through a diverse product offering, which helps mitigate risk. TCM Ltd's commitment to innovation and operational excellence underpins its ability to maintain a competitive edge in the commodity chemicals industry. It balances its manufacturing capabilities with a sharp focus on trading, ensuring seamless distribution and optimal market penetration. The company has a well-established infrastructure and logistics network. TCM Ltd provides specialized chemicals and related products to many industries including agricultural and industrial. By strategically managing its diverse portfolio and continually seeking opportunities for growth and diversification, TCM Ltd strives to be a reliable and valuable partner in the commodity chemicals market.

Company Details

Symbol:TCMLMTD
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Mr. Joseph Varghese
MD & Executive Director
Mr. M. P. Mohanan
Chief Financial Officer
Mr. Gokul V. Shenoy C.S.
Finance Controller, Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date

TCMLMTD Share Price: Frequently Asked Questions

What is the current share price of TCM Ltd?

TCM Ltd (TCMLMTD) trades at ₹49.40 on NSE and BSE. Market cap ₹54.71 (Cr). Educational data only.

What is the P/E ratio of TCM Ltd?

TCM Ltd has a P/E of 364.75x vs industry average 20.98x.

What is the Bull Run score for TCM Ltd?

TCM Ltd has a Bull Run score of 33.9/100 based on 25+ financial parameters.

Does TCM Ltd pay dividends?

TCM Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of TCM Ltd?

TCM Ltd has ROE of 6.04%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of TCM Ltd?

TCM Ltd has debt-to-equity of 0.75.

Is TCM Ltd a good investment?

Bull Run gives TCM Ltd a score of 33.9/100. This is not investment advice — consult a SEBI-registered advisor.